Hydrogels in pharmaceutical formulations

被引:2955
|
作者
Peppas, NA
Bures, P
Leobandung, W
Ichikawa, H
机构
[1] Purdue Univ, Sch Chem Engn, Biomat & Drug Delivery Labs, W Lafayette, IN 47907 USA
[2] Kobe Gakuin Univ, Fac Pharmaceut Sci, Kobe, Hyogo, Japan
关键词
pH-sensitive hydrogels; temperature-sensitive hydrogels; application in drug delivery; drug release; polymer network structure;
D O I
10.1016/S0939-6411(00)00090-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The availability of large molecular weight protein- and peptide-based drugs due to the recent advances in the field of molecular biology has given us new ways to treat a number of diseases. Synthetic hydrogels offer a possibly effective and convenient way to administer these compounds. Hydrogels are hydrophilic, three-dimensional networks, which are able to imbibe large amounts of water or biological fluids, and thus resemble, to a large extent, a biological tissue. They are insoluble due to the presence of chemical (tie-points, junctions) and/or physical crosslinks such as entanglements and crystallites. These materials can be synthesized to respond to a number of physiological stimuli present in the body, such as pH, ionic strength and temperature. The aim of this article is to present a concise review on the applications of hydrogels in the pharmaceutical field, hydrogel characterization and analysis of drug release from such devices. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:27 / 46
页数:20
相关论文
共 50 条
  • [1] PHARMACEUTICAL FORMULATIONS OF ANTHRALIN
    WHITEFIELD, M
    BRITISH JOURNAL OF DERMATOLOGY, 1981, 105 : 28 - 32
  • [2] Hydrolysis in pharmaceutical formulations
    Waterman, KC
    Adami, RC
    Alsante, KM
    Antipas, AS
    Arenson, DR
    Carrier, R
    Hong, JY
    Landis, MS
    Lombardo, F
    Shah, JC
    Shalaev, E
    Smith, SW
    Wang, H
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2002, 7 (02) : 113 - 146
  • [3] VITAMINS IN PHARMACEUTICAL FORMULATIONS
    DERITTER, E
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (10) : 1073 - 1096
  • [4] Pharmaceutical excipients and pediatric formulations
    Yochana, Srivari
    Yu, Meiki
    Alvi, Mohammed
    Varenya, Sri
    Chatterjee, Parnali
    CHIMICA OGGI-CHEMISTRY TODAY, 2012, 30 (05) : 56 - 61
  • [5] Pharmaceutical Peptide Formulations.
    Birr, P. E.
    Buckel, B.
    Kuenzel, S.
    Birr, Christian
    JOURNAL OF PEPTIDE SCIENCE, 2010, 16 : 179 - 180
  • [6] Determination of Mizolastine in pharmaceutical formulations
    Sreelakshmi, A.
    Rao, G. Devala
    Babu, G. Sudhakara Sai
    ORIENTAL JOURNAL OF CHEMISTRY, 2010, 26 (01) : 239 - 242
  • [7] Determination of carbamazepine in pharmaceutical formulations
    da Silva Solon, Lilian Grace
    Maia de Oliveira, Ana Isabel
    Bernardo Guerra, Gerlane Coelho
    Lira Soares, Luiz Alberto
    de Araujo, Aurigena Antunes
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 46 (03) : 509 - 513
  • [8] PHARMACEUTICAL FORMULATIONS - SUSPENSIONS AND SOLUTIONS
    EDMAN, P
    JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 1994, 7 : S3 - S6
  • [9] Thixotropic property in pharmaceutical formulations
    Lee, Chi H.
    Moturi, Venkat
    Lee, Yugyung
    JOURNAL OF CONTROLLED RELEASE, 2009, 136 (02) : 88 - 98
  • [10] Triboluminescence from Pharmaceutical Formulations
    Smith, Casey J.
    Griffin, Scott R.
    Eakins, Gregory S.
    Deng, Fengyuan
    White, Julia K.
    Thirunahari, Satyanarayana
    Ramakrishnan, Srividya
    Sangupta, Atanu
    Zhang, Siwei
    Novak, Julie
    Liu, Zhen
    Rhodes, Timothy
    Simpson, Garth J.
    ANALYTICAL CHEMISTRY, 2018, 90 (11) : 6893 - 6898